Bank Of America Corp Pax Medica, Inc. Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.76 - $2.08 $2,819 - $7,716	-3,710 Reduced 88.12%	500 $0
Q1 2023 May 12, 2023	SELL	$1.42 - $3.62 $14,677 - $37,416	-10,336 Reduced 71.06%	4,210 $8,000
Q4 2022 Feb 10, 2023	BUY	$1.4 - $53.55 $20,364 - $778,938	14,546 New	14,546 $29,000

Ticker PXMD
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,779,500
Market Cap $1.41M
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.